v3.26.1
SCHEDULE OF UNREALIZED GAINS AND LOSSES (Details) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Investment in equity securities, beginning period fair value $ 389,100,000 $ 22,653,225
Adjustment to Fair Value 300,000 365,346,775
Investment in equity securities, ending period fair value 389,400,000 388,000,000
GMP Biotechnology Limited [Member]    
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Investment in equity securities, beginning period fair value 388,000,000 22,653,225
Adjustment to Fair Value 365,346,775
Investment in equity securities, ending period fair value 388,000,000 $ 388,000,000
Lunai Bioworks, Inc [Member]    
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Investment in equity securities, beginning period fair value 1,100,000  
Adjustment to Fair Value 300,000  
Investment in equity securities, ending period fair value $ 1,400,000